-
Entity
-
Individual
-
Location
-
C/O Adaptimmune Therapeutics Plc, 60 Jubilee Ave, Milton Park, Abingdon, Oxfordshire, United Kingdom
-
Summary
-
The estimated net worth of William Bertrand is at least $1.54M dollars as of June 17, 2024. William Bertrand is the Director of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $1.53M. William Bertrand is the Chief Operating Officer of Adaptimmune Therapeutics PLC and owns shares of Adaptimmune Therapeutics PLC (ADAP) stock worth about $13.6K.